The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

BACKGROUND: MIV-711 is a highly potent and selective cathepsin K inhibitor. The current article summarizes the therapeutic effects of MIV-711 on joint pathology in rabbits subjected to anterior cruciate ligament transection (ACLT), and the prophylactic effects on joint pathology in dogs subjected to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindström, Erik, Rizoska, Biljana, Tunblad, Karin, Edenius, Charlotte, Bendele, Alison M., Maul, Don, Larson, Michael, Shah, Neha, Yoder Otto, Valerie, Jerome, Chris, Grabowska, Urszula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845353/
https://www.ncbi.nlm.nih.gov/pubmed/29523155
http://dx.doi.org/10.1186/s12967-018-1425-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845353/
https://www.ncbi.nlm.nih.gov/pubmed/29523155
http://dx.doi.org/10.1186/s12967-018-1425-7

Ejemplares similares